Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris - A multicenter, randomised, double-blind controlled study.
Summary of "Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris - A multicenter, randomised, double-blind controlled study."
Background:  Oral antibiotics in association with a topical retinoid with or without benzoyl peroxide (BPO) are the recommended first-line option in the treatment of moderate to severe acne vulgaris. Objectives:  To evaluate the efficacy and safety of oral lymecycline 300 mg with adapalene 0.1%-BPO 2.5% (A/BPO) fixed-dose gel in comparison with oral lymecycline 300 mg with a vehicle gel in subjects with moderate to severe acne vulgaris. Methods:  378 subjects were randomised in a double-blind controlled trial to receive once daily lymecycline with either A/BPO or vehicle for 12 weeks. Evaluations included percentage changes from baseline in lesion counts, success rate (subjects "clear" or "almost clear"), skin tolerability, adverse events and patients' satisfaction. Results:  The median percent reduction from baseline in total lesion counts at week 12 was significantly higher (p<0.001) in the lymecycline with A/BPO group (-74.1%) than in the lymecycline with vehicle group (-56.8%). The success rate was significantly higher (47.6%versus 33.7%, p=0.002) in subjects treated with lymecycline and A/BPO. Both inflammatory and non-inflammatory lesions were significantly reduced at week 12 (both p<0.001) with a rapid onset of action from week 2 for non-inflammatory lesions (p<0.001) and week 4 for inflammatory lesions (p=0.005). The A/BPO and lymecycline combination was well-tolerated. The proportion of satisfied and very satisfied subjects was similar in both groups, but the number in the A/BPO group who were "very satisfied" was significantly greater (p=0.031). Conclusions:  These results demonstrated the clinical benefit of combining A/BPO with lymecycline in the treatment of moderate to severe acne vulgaris.
Affiliation
Hôpital Hotel Dieu, Department of Dermato-Oncology, Nantes, France Department of Dermatology, Goethe-University Hospital, Frankfurt am Main, Germany UNIFESP - Universidade Federal de São Paulo, São Paulo, Brazil Department of Dermatology, Juárez Hospi
Journal Details
This article was published in the following journal.
Name: The British journal of dermatology
ISSN: 1365-2133
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21495995
- DOI: http://dx.doi.org/10.1111/j.1365-2133.2011.10374.x
Medical and Biotech [MESH] Definitions
Benzoyl Peroxide
A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS. It is used also as a bleach in the food industry.
Drug Therapy, Combination
Therapy with two or more separate preparations given for a combined effect.
Ethinyl Estradiol-norgestrel Combination
ETHINYL ESTRADIOL and NORGESTREL given in fixed proportions. It has proved to be an effective contraceptive (CONTRACEPTIVES, ORAL, COMBINED).
Oral Medicine
A branch of dentistry dealing with diseases of the oral and paraoral structures and the oral management of systemic diseases. (Hall, What is Oral Medicine, Anyway? Clinical Update: National Naval Dental Center, March 1991, p7-8)
Lymecycline
A semisynthetic antibiotic related to TETRACYCLINE. It is more readily absorbed than TETRACYCLINE and can be used in lower doses.
PubMed Articles
Abstract The adapalene-benzoyl peroxide (adapalene-BPO) combination gel is efficacious and safe in the treatment of acne vulgaris. We aimed in this pooled analysis to determine whether the adapalene-B...
Background: Patients with acne vulgaris often have impaired quality of life (QOL). The fixed-dose combination of benzoyl peroxide 5%/clindamycin 1% gel (BPO/C) topical gel provides an earlier onset of...
Combination therapy addressing multiple pathogenic factors should be used to achieve optimal outcomes in treating acne. The following study demonstrated both safety and efficacy of fixed-dose clindamy...
Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
This single-center, investigator-blinded, randomized, split-face, phase 4 study compared the irritation potential of tretinoin gel microsphere (TGM) 0.04% in a pump dispenser with adapalene 0.1% plus...
Topical dose justification: benzoyl peroxide concentrations.
Abstract Background: Benzoyl peroxide (BPO) is widely utilized in acne treatment as an alternative to antibiotics against which Propionibacterium acnes becomes more resistant. Objective: This overv...
Clinical Trials
This is a multi-center, randomized, double-blind, parallel group study with 12 weeks of treatment of acne vulgaris. Efficacy and safety evaluations will be performed at Screening (safety...
The purpose of this study is to demonstrate the non-inferior efficacy of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel when compared to Clindamycin 1% / Benzoyl Peroxide 5% Gel in Subjects wi...
This is a single-blind (blinded expert grader), randomized, half-face study being conducted at one clinical site. On 1 side of the face, the subject will apply 1 of the 2 test products, an...
A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne
Multi-center, single-blind, randomized, comparative, split-face study. The duration of the study is 8 weeks. Commencing at baseline, subjects will apply once daily both clindamycin and be...
The purpose of this study is to compare the safety and efficacy of 5% Dapsone Topical Gel, (DTG) twice daily in combination with once daily vehicle control, adapalene gel 0.1% or benzoyl p...
